Entrada Therapeutics started at outperform with $22 stock price target at Oppenheimer
1 min read[Entrada Therapeutics started at outperform with $22 stock price target at Oppenheimer
Tomi Kilgore
2024-01-05 08:39:00
All news and articles are copyrighted to the respective authors and/or News Broadcasters. VIXC.Com is an independent Online News Aggregator
Read more from original source here…